# ADAPALENE
> **ANDA201000** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2014-10-27
## Drug
- **FDA Application Number:** ANDA201000
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ADAPALENE
- **Generic name:** ADAPALENE
- **Active ingredients:** ADAPALENE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS MID ATLANTIC
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2014-10-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201000)
---
*MORVS · CC0 1.0*